Home

About Us

Our Solutions

News

Contact Us

Home

About Us

Our Solutions

News

Contact Us

Latest news and updates

  • Aug 25, 2024

    Mark drove from the Netherlands to Norway to save Misty with a new cancer treatment

  • Aug 25, 2024

    Mark drove from the Netherlands to Norway to save Misty with a new cancer treatment

  • Apr 8, 2024

    Lung metastasis – Patient recruitment

  • Apr 8, 2024

    Lung metastasis – Patient recruitment

  • Mar 15, 2024

    Alv B receives study approval for Alvacan 4000

  • Mar 15, 2024

    Alv B receives study approval for Alvacan 4000

Alv B AS is a Norwegian biotech company that develops cutting-edge, cost-effective cancer treatments for dogs. We benefit from a forward-thinking team well-versed in the latest advances in cancer research on humans, as well as dogs.

Navigation

About us

Our Solutions

News

Contact

Contact us

+47 93423539

contact@alvb.no

www.alvb.no

Oslo Science Park

Alv B AS is a Norwegian biotech company that develops cutting-edge, cost-effective cancer treatments for dogs. We benefit from a forward-thinking team well-versed in the latest advances in cancer research on humans, as well as dogs.

Navigation

About us

Our Solutions

News

Contact

Contact us

+47 93423539

contact@alvb.no

www.alvb.no

Oslo Science Park

Alv B AS is a Norwegian biotech company that develops cutting-edge, cost-effective cancer treatments for dogs. We benefit from a forward-thinking team well-versed in the latest advances in cancer research on humans, as well as dogs.

Navigation

About us

Our Solutions

News

Contact

Contact us

+47 93423539

contact@alvb.no

www.alvb.no

Oslo Science Park